We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 10,000 results
  1. Influence of variant-specific mutations, temperature and pH on conformations of a large set of SARS-CoV-2 spike trimer vaccine antigen candidates

    SARS-CoV-2 subunit vaccines continue to be the focus of intense clinical development worldwide. Protein antigens in these vaccines most commonly...

    Matthew Stuible, Joseph D. Schrag, ... Yves Durocher in Scientific Reports
    Article Open access 01 October 2023
  2. Automated quantification of avian influenza virus antigen in different organs

    As immunohistochemistry is valuable for determining tissue and cell tropism of avian influenza viruses (AIV), but time-consuming, an artificial...

    Maria Landmann, David Scheibner, ... Reiner Ulrich in Scientific Reports
    Article Open access 16 April 2024
  3. Challenges in the discovery of tumor-specific alternative splicing-derived cell-surface antigens in glioma

    Despite advancements in cancer immunotherapy, solid tumors remain formidable challenges. In glioma, profound inter- and intra-tumoral heterogeneity...

    Takahide Nejo, Lin Wang, ... Hideho Okada in Scientific Reports
    Article Open access 16 March 2024
  4. Antigen presentation by B cells enables epitope spreading across an MHC barrier

    Circumstantial evidence suggests that B cells may instruct T cells to break tolerance. Here, to test this hypothesis, we used a murine model in which...

    Cecilia Fahlquist-Hagert, Thomas R. Wittenborn, ... Søren E. Degn in Nature Communications
    Article Open access 31 October 2023
  5. Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting

    Chimeric antigen receptor (CAR) T cell therapeutic responses are hampered by limited T cell trafficking, persistence, and durable anti-tumor activity...

    Eric Hee Jun Lee, John P. Murad, ... Saul J. Priceman in Nature Communications
    Article Open access 07 August 2023
  6. TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification

    T cell recognition of human leukocyte antigen (HLA)-presented tumor-associated peptides is central for cancer immune surveillance. Mass spectrometry...

    Naomi Hoenisch Gravel, Annika Nelde, ... Juliane S. Walz in Nature Communications
    Article Open access 17 November 2023
  7. Antigen test swabs are comparable to nasopharyngeal swabs for sequencing of SARS-CoV-2

    Viral genomic surveillance has been integral in the global response to the SARS-CoV-2 pandemic. Surveillance efforts rely on the availability of...

    Sayf Al-Deen Hassouneh, Alexa Trujillo, ... Taj Azarian in Scientific Reports
    Article Open access 12 July 2023
  8. Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients

    Disease-modifying therapies (DMT) administered to patients with multiple sclerosis (MS) can influence immune responses to SARS-CoV-2 and vaccine...

    Sara De Biasi, Domenico Lo Tartaro, ... Andrea Cossarizza in Nature Communications
    Article Open access 29 March 2024
  9. Catch bond models may explain how force amplifies TCR signaling and antigen discrimination

    The TCR integrates forces in its triggering process upon interaction with pMHC. Force elicits TCR catch-slip bonds with strong pMHCs but slip-only...

    Hyun-Kyu Choi, Peiwen Cong, ... Cheng Zhu in Nature Communications
    Article Open access 05 May 2023
  10. Discrete LAT condensates encode antigen information from single pMHC:TCR binding events

    LAT assembly into a two-dimensional protein condensate is a prominent feature of antigen discrimination by T cells. Here, we use single-molecule...

    Darren B. McAffee, Mark K. O’Dair, ... Jay T. Groves in Nature Communications
    Article Open access 02 December 2022
  11. HER2-antigen-specific humoral immune response in breast cancer lymphocytes transplanted in hu-PBL hIL-4 NOG mice

    The status of humoral immunity of cancer patients is not clear compared to cellular immunity because the ability of specific antibody production is...

    Yusuke Ohno, Shino Ohshima, ... Yoshie Kametani in Scientific Reports
    Article Open access 17 June 2021
  12. Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors

    The success of cancer immunotherapy depends in part on the strength of antigen recognition by T cells. Here, we characterize the T cell receptor...

    Julien Schmidt, Johanna Chiffelle, ... Alexandre Harari in Nature Communications
    Article Open access 06 June 2023
  13. Antigen discrimination by T cells relies on size-constrained microvillar contact

    T cells use finger-like protrusions called ‘microvilli’ to interrogate their targets, but why they do so is unknown. To form contacts, T cells must...

    Edward Jenkins, Markus Körbel, ... David Klenerman in Nature Communications
    Article Open access 23 March 2023
  14. Usefulness of MRI targeted prostate biopsy for detecting clinically significant prostate cancer in men with low prostate-specific antigen levels

    We aimed to evaluate the detection rates of prostate cancer (PCa) and clinically significant PCa (csPCa) using magnetic resonance imaging-targeted...

    Seokhwan Bang, Jiwoong Yu, ... Seong Soo Jeon in Scientific Reports
    Article Open access 09 November 2021
  15. The circadian clock influences T cell responses to vaccination by regulating dendritic cell antigen processing

    Dendritic cells play a key role in processing and presenting antigens to naïve T cells to prime adaptive immunity. Circadian rhythms are known to...

    Mariana P. Cervantes-Silva, Richard G. Carroll, ... Annie M. Curtis in Nature Communications
    Article Open access 05 December 2022
  16. Public health-focused use of COVID-19 rapid antigen and PCR tests

    During the Covid-19 pandemic, accurate PCR tests were augmented by the cheap, rapid, and logistically convenient, yet less sensitive antigen tests....

    Yonatan Woodbridge, Yair Goldberg, ... Amit Huppert in Scientific Reports
    Article Open access 16 January 2024
  17. A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile

    Prostate-specific membrane antigen (PSMA) is a promising target for the treatment of advanced prostate cancer (PC) and various solid tumors. Although...

    Srikanth Boinapally, Hye-Hyun Ahn, ... Martin G. Pomper in Scientific Reports
    Article Open access 29 March 2021
  18. Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma

    Allogeneic natural killer (NK) cell adoptive transfer is a promising treatment for several cancers but is less effective for the treatment of...

    Frank Cichocki, Ryan Bjordahl, ... Jeffrey S. Miller in Nature Communications
    Article Open access 29 November 2022
  19. Dengue NS1 antigen kit shows high sensitivity for detection of recombinant dengue virus-2 NS1 antigen spiked with Aedes aegypti mosquitoes

    Dengue, caused by the dengue virus (DENV) is a significant vector-borne disease. In absence of a specific treatment and vaccine, dengue is becoming a...

    Philip Raj Abraham, Bharathy R, ... Ashwani Kumar in Scientific Reports
    Article Open access 08 December 2021
  20. Impact of antigen test target failure and testing strategies on the transmission of SARS-CoV-2 variants

    Population testing remains central to COVID-19 control and surveillance, with countries increasingly using antigen tests rather than molecular tests....

    Claudia Del Vecchio, Bethan Cracknell Daniels, ... Andrea Crisanti in Nature Communications
    Article Open access 05 October 2022
Did you find what you were looking for? Share feedback.